AI tools in healthcare are increasingly being positioned as alternatives to ChatGPT—not because they write better text, but because they claim to do work end-to-end: monitor signals, decide what to do next, and trigger actions with minimal user effort. A recent headline about MediKarma points to this shift, describing a clinical intervention study that “validates agentic AI” and reports a major reduction in A1C. Regardless of the exact results, the story illustrates a broader trend: organizations want friction-free, task-completing AI, not just conversational assistance.
What “agentic AI” usually means (and how it differs from ChatGPT)
In most product and research contexts, agentic AI refers to systems that can:
- Set or pursue goals (e.g., improving patient adherence or nudging lifestyle changes)
- Plan multi-step actions rather than answering a single prompt
- Use tools and integrations (EHRs, reminders, sensors, messaging, scheduling)
- Operate continuously (monitor → evaluate → intervene → learn), not only when a user chats
ChatGPT-style tools are often interaction-driven: the user initiates, asks, and receives an answer. Agentic systems aim to be workflow-driven: the system initiates or orchestrates tasks based on context. In healthcare, that distinction matters because outcomes typically depend on sustained behavior change and timely interventions—areas where “one-off” conversations may not be enough.
Why “friction-free” matters in clinical settings
“Friction” is anything that prevents consistent use: complicated interfaces, manual tracking, unclear next steps, or interventions that come too late. A “friction-free” AI tool typically tries to reduce this by:
- Collecting data automatically (device, app, or check-in flows)
- Delivering actionable guidance at the right moment (messages, reminders, micro-coaching)
- Escalating to humans when needed (care teams, coaches, clinicians)
- Closing the loop (confirming actions happened, adapting future recommendations)
In other words, the product goal is less “answer my question” and more “help me do the thing consistently.”
Interpreting the A1C reduction headline carefully
A1C is a long-term glycemic marker, and large improvements are clinically meaningful. However, headline numbers can hide key details. When evaluating claims like “50% A1C reduction,” it’s important to ask:
- Study design: Was it randomized? Controlled? Observational? How were participants selected?
- Baseline A1C: Percent reductions look bigger when starting values are very high.
- Duration: Over how many months was A1C measured, and was the effect sustained?
- Intervention components: Was it purely AI, or AI + human coaching + medication changes?
- Adherence and dropout rates: Who stayed in the program, and who left?
- Clinical oversight: What guardrails existed for safety, escalation, and contraindications?
Agentic AI can be part of a strong intervention program, but outcomes typically come from a system (protocols, engagement design, escalation paths, clinical governance), not a model alone.
How agentic healthcare tools can outperform general chatbots
General-purpose chatbots are helpful for education, drafting messages, or explaining lab results in plain language. But agentic tools can have advantages in healthcare workflows:
- Context persistence: remembering goals, constraints, medication schedules, and prior interventions
- Automation: triggering reminders, follow-ups, and check-ins without repeated prompting
- Personalization: adapting frequency, tone, and interventions based on engagement signals
- Integration: connecting to clinical pathways and data sources (where permitted)
These capabilities make the tool less like a “chat partner” and more like a care-navigation layer that can coordinate actions over time.
Key evaluation checklist for AI tools marketed as “ChatGPT alternatives”
If you’re comparing healthcare AI tools that claim to be agentic or outcome-driven, focus on practical questions:
- Evidence: What peer-reviewed data or independently verifiable studies exist?
- Safety & governance: How are hallucinations, risky advice, and edge cases handled?
- Human-in-the-loop: When does the tool escalate to clinicians or coaches?
- Data privacy: What data is collected, how it’s stored, and how it’s used for training?
- Integration readiness: Can it connect with existing systems (EHR, devices, scheduling) securely?
- Behavioral design: Does it meaningfully reduce friction and sustain engagement?
Takeaway
The MediKarma headline highlights a larger industry direction: AI products are moving from conversational assistants toward agentic systems designed to deliver measurable outcomes. In healthcare, the difference isn’t just technological—it’s operational. The strongest “ChatGPT alternatives” won’t simply chat; they’ll integrate into care pathways, automate follow-through, and demonstrate results with transparent clinical evidence.